Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Piper Sandler 

Deciphera Pharmaceuticals diskutieren

Deciphera Pharmaceuticals

WKN: A2H48H / Symbol: DCPH / Name: Deciphera Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

23,40 €
-

Einschätzung Buy
Rendite (%) 114,22 %
Kursziel 21,66
Veränderung
Endet am 30.10.24

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock.
Ratings data for DCPH provided by MarketBeat

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Jonestrading from a "hold" rating to a "buy" rating.
Ratings data for DCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 117,98 %
Kursziel 28,29
Veränderung
Endet am 31.10.24

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at HC Wainwright from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 110,62 %
Kursziel 20,79
Veränderung
Endet am 31.10.24

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 81,47 %
Kursziel 21,40
Veränderung
Endet am 08.02.25

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at Stifel Nicolaus from $22.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat